枯草芽胞杆菌蛋白质表达分泌系统发展及展望

枯草芽胞杆菌作为革兰阳性模式菌株是基础研究和工业应用的常用宿主细胞。介绍了枯草芽胞杆菌中蛋白合成和分泌过程中的重要步骤及重要调控位点。在枯草芽胞杆菌蛋白表达及分泌系统中,可以针对目标基因在体内的转录、翻译、折叠、转运和菌株改造等方面对表达分泌系统进行优化改良,针对不同的目标蛋白,可进行不同优化模块的组装和拼搭,以达到针对目标蛋白产物定制化地提高产量和分泌量的目的。在未来,随着基因编辑和合成生物技术的发展,菌株改良策略的不断优化,枯草芽胞杆菌将会在工业生产蛋白质制品领域发挥更大的应用价值。     

枯草芽孢杆菌代谢工程改造的策略与工具

作为一种食品安全级的典型工业模式微生物,枯草芽孢杆菌Bacillus subtilis由于具有非致病性、胞外分泌蛋白能力强以及无明显的密码子偏爱性等特点,现已被广泛应用于代谢工程领域。近年来,随着分子生物学和基因工程技术等的迅速发展,多种研究策略和工具被用于构建枯草芽孢杆菌底盘细胞进行生物制品的高效合成。文中从启动子工程、基因编辑、基因回路、辅因子工程以及途径酶组装等方面介绍枯草芽孢杆菌在代谢工程领域的研究历程,并总结其在生物制品生产中的相关应用,最后对其未来的研究方向进行展望。     

枯草芽孢杆菌形成生物被膜的研究进展

生物被膜是菌体在自然界中一种常见的生存状态,直接影响着人类生产和生活的各个方面。枯草芽孢杆菌是重要的工业菌株,同时也是研究生物被膜的模式菌株。本文结合作者目前的研究,综述了目前对枯草芽孢杆菌形成生物被膜研究所取得的重要进展,包括枯草芽孢杆菌形成生物被膜的主要过程、特征、研究模型及分子调控机制,并提出了今后研究的热点问题。     

基于全基因组序列比对的枯草芽孢杆菌噬菌体侵染能力分析

目前,在美国国家生物技术信息中心(NCBI)数据库中已报道数量众多的枯草芽孢杆菌及其噬菌体的全基因组序列,这为我们利用全基因组比对手段研究枯草芽孢杆菌噬菌体的侵染能力提供了数据基础。本研究从NCBI基因组数据库中下载具有完整序列的枯草芽孢杆菌及噬菌体的基因组及相应的蛋白质序列,利用BLAST软件进行基因组序列比对,得出枯草芽孢杆菌与噬菌体之间的关系。通过利用R语言等软件对噬菌体侵染枯草芽孢杆菌的能力进行分析。然后利用Clustalx和Treeview软件构建进化树,得出枯草芽孢杆菌之间的亲缘性关系,最后对枯草芽孢杆菌蛋白质进行COG注释。结果表明:在65株枯草芽孢杆菌噬菌体中,Bacillus_phage_SPBc2和Bacillus_phage_ph IS3501的侵染能力最强,而Bacillus_phage_phi AGATE等3株噬菌体的侵染能力较弱。在37株枯草芽孢杆菌中Bacillus subtilis ATCC 49760的易感性较强,Bacillus subtilis RO-NN-1等8株对枯草芽孢杆菌噬菌体的抗性较强。本研究利用基因组比对的方法对枯草芽孢杆菌噬菌体侵染宿主的能力以及枯草芽孢杆的蛋白质功能进行了分析,为后续进一步研究枯草芽孢杆菌噬菌体侵染能力及其蛋白质功能提供参考。     

枯草芽胞杆菌基因组删减对异源酶表达影响的研究进展

枯草芽胞杆菌作为一种遗传背景清晰、基因编辑成熟的革兰氏阳性菌,是多种重要工业酶的生产宿主。随着转录组、蛋白质组、代谢组等多组学测序和分析技术的发展,通过合理设计简化枯草芽胞杆菌基因组,减少细胞内冗余的调控和代谢网络,使得细胞更精简且便于控制,展现出了枯草芽胞杆菌作为异源酶表达宿主细胞的应用潜力。本文简要综述了枯草芽胞杆菌基因组删减的研究进展,归纳了必需基因的确定方法,重点介绍了枯草芽胞杆菌通过删减基因组提升异源酶表达的研究进展及删减策略,充分展示了枯草芽胞杆菌基因组删减在构建异源酶表达底盘细胞中的重要作用。     

感受态还是芽胞？细胞命运决定的遗传调控网络

枯草芽胞杆菌作为一般认为安全(GRAS,Generally recognized as safe)菌株,被广泛应用于饲料、食品、生物防治等领域,同时,枯草芽胞杆菌作为表达宿主在工业酶的应用中扮演重要角色。然而,低效的芽胞形成率与感受态效率极大限制了枯草芽胞杆菌的应用潜力。尽管已有大量关于芽胞形成与感受态形成的分子遗传机制的研究报道,但是通过遗传改造提高枯草芽胞杆菌芽胞形成率与感受态效率的研究报道并不多。可能的原因是芽胞形成与感受态形成作为枯草芽胞杆菌生长后期两个主要的发育事件,受胞内复杂的遗传调控机制操纵,且两个遗传通路之间存在相互调控关系,对遗传改造工作形成挑战。随着基因工程与代谢工程研究的不断发展,积累了大量关于细胞生长、代谢与发育等方面的遗传信息,通过综合这些遗传信息构建细胞遗传调控网络,用于指导生产实践,已经成为当前研究的热点之一。基于此,本文简要概述了枯草芽胞杆菌芽胞形成和感受态形成的遗传通路,初步探讨了芽胞形成与感受态形成之间的遗传调控网络,及细胞在生长后期的遗传决定机制,并讨论了该遗传调控网络对枯草芽孢杆菌及其近缘种应用研究的指导作用。     

谷氨酸棒杆菌耐受胁迫机制及工业鲁棒性合成生物学研究进展

谷氨酸棒杆菌Corynebacterium glutamicum作为一般被认为具有生物安全性的一种模式工业微生物,不仅在发酵工业中成功用于大规模生产氨基酸,而且具有合成多种新型化学品的潜力。谷氨酸棒杆菌菌株在生产化合物时,经常会受到各种逆境条件的胁迫,从而降低细胞活力和生产性能。合成生物学的发展为提高谷氨酸棒杆菌的鲁棒性提供了新的技术手段。本文总结了谷氨酸棒杆菌应对发酵过程中各种胁迫的耐受机制。同时,重点介绍提高谷氨酸棒杆菌底盘细胞鲁棒性和耐受性的合成生物学新策略,包括挖掘新的抗逆元件、改造转录调控因子、利用适应性进化策略挖掘抗逆功能模块等。最后,从生物传感器、转录调控因子的筛选和设计、多种调控元件利用等方面对提高谷氨酸棒杆菌底盘细胞鲁棒性进行了展望。     

枯草芽孢杆菌无标记遗传操作技术研究进展

枯草芽孢杆菌是革兰氏阳性菌的模式生物,长期以来在代谢工程和工业微生物领域扮演重要角色。枯草芽孢杆菌无标记遗传操作技术对后基因组时代的基因功能研究和菌株生理特性的改造起着关键作用。综述枯草芽孢杆菌无标记遗传操作所使用的负筛选标记基因,总结目前主流的无标记遗传操作的策略,并提出枯草芽孢杆菌无标记遗传操作技术面临的主要问题和发展方向。     

多效调控基因degU32(Hy),degQa和degR对枯草芽孢杆菌Ki-2-132生长和蛋白酶发酵的影响

通过向枯草芽孢杆菌Ki-2-132染色体和／或细胞质导入来自枯草杆菌168菌株的degU32（Hy）和degR基因,以及来自芽孢杆菌解淀粉菌株（Bacillus amyloliquefaciens）的degQa基因,对上述基因对枯草芽孢杆菌Ki-2-132细胞的生长、孢子发生、蛋白酶发酵的影响进行了研究。尽管上述多效调控基因来自不同的芽孢杆菌种和菌株,它们在枯草芽孢杆菌Ki-2-132中依然表现多效性。枯草杆菌Ki-2-132degU32（Hy）表现出增高了的蛋白酶产量;当和质粒或染色体上的degQa基因协作,可以进一步依赖葡萄糖的水平和degQa的基因剂量影响细胞生长,增加蛋白酶产量,以及影响孢子的形成。与此不同,degR在degU32（Hy）突变体中并不显著影响其蛋白酶的产量,这一发现支持DegR蛋白通常稳定磷酸化的DegU,而其在degU32（Hy）菌株中不再进一步放大该突变体内已被磷酸化的DegU的调控作用。     

利用非经典分泌蛋白质实现脂肪酶A的分泌表达

【目的】以枯草芽孢杆菌脂肪酶A(Lipase A)为报告蛋白,尝试利用4种非经典分泌蛋白质及其前50个氨基酸作为分泌信号以实现其分泌表达。【方法】我们扩增了脂肪酶A的编码基因和非经典分泌蛋白质的编码序列,构建了8种针对脂肪酶A的分泌表达载体,并转化至枯草芽孢杆菌WB800菌株,通过测定重组菌株的酶活、利用蛋白质电泳和免疫印迹等技术检测脂肪酶A的分泌情况【结果】以Pdh A的氨基酸序列和Sod A、Eno的前50氨基酸序列作为分泌信号的重组菌株较好的实现了脂肪酶A的分泌表达。【结论】部分非经分泌蛋白质的编码基因或其前50个氨基酸序列能够引导脂肪酶A分泌至细胞外。     

Bacillus subtilis as cell factory for pharmaceutical proteins: a biotechnological approach to optimize the host organism

Bacillus subtilis is a rod-shaped, Gram-positive soil bacterium that secretes numerous enzymes to degrade a variety of substrates, enabling the bacterium to survive in a continuously changing environment. These enzymes are produced commercially and this production represents about 60% of the industrial-enzyme market. Unfortunately, the secretion of heterologous proteins, originating from Gram-negative bacteria or from eukaryotes, is often severely hampered. Several bottlenecks in the B. subtilis secretion pathway, such as poor targeting to the translocase, degradation of the secretory protein, and incorrect folding, have been revealed. Nevertheless, research into the mechanisms and control of the secretion pathways will lead to improved Bacillus protein secretion systems and broaden the applications as industrial production host. This review focuses on studies that aimed at optimizing B. subtilis as cell factory for commercially interesting heterologous proteins.     

Engineering antibiotic production and overcoming bacterial resistance

Progress in DNA technology, analytical methods and computational tools is leading to new developments in synthetic biology and metabolic engineering, enabling new ways to produce molecules of industrial and therapeutic interest. Here, we review recent progress in both antibiotic production and strategies to counteract bacterial resistance to antibiotics. Advances in sequencing and cloning are increasingly enabling the characterization of antibiotic biosynthesis pathways, and new systematic methods for de novo biosynthetic pathway prediction are allowing the exploration of the metabolic chemical space beyond metabolic engineering. Moreover, we survey the computer-assisted design of modular assembly lines in polyketide synthases and non-ribosomal peptide synthases for the development of tailor-made antibiotics. Nowadays, production of novel antibiotic can be tranferred into any chosen chassis by optimizing a host factory through specific strain modifications. These advances in metabolic engineering and synthetic biology are leading to novel strategies for engineering antimicrobial agents with desired specificities.     

Associated roles of hemolysin and p60 protein for the intracellular growth of Bacillus subtilis

Hemolysin expressing Bacillus subtilis strain (B. subtilis ble/hlA) was used as a carrier for listerial protein p60 to study the impact of this protein on bacterial virulence independent of other gene products of Listeria monocytogenes. Bacillus subtilis ble/hlyA exhibited longer cell chains than B. subtilis ble/hlyA/iap. Recombinant Bacillus strains are able to adhere to the mouse macrophage-like J774 and human epithelial-like Int407 cell lines. The bacterial number of B. subtilis ble/hlyA/iap strain that adhered to the Int407 cell lines was 2.52-fold higher, and its invasion level strain was 2.66-fold higher than that observed for the hemolytic strain. Microscopy analysis of infected monolayers showed that recombinant B. subtilis cells were localized inside the cytoplasm of epithelial cells, near to the nuclei, in cellular compartments with low internal pH. Furthermore, in cells infected with bacteria, the actin structures rapidly changed and accumulation of a fat, wide actin layer around the nucleus zone was observed.     

Assembly of minicellulosomes on the surface of Bacillus subtilis

To cost-efficiently produce biofuels, new methods are needed to convert lignocellulosic biomass into fermentable sugars. One promising approach is to degrade biomass using cellulosomes, which are surface-displayed multicellulase-containing complexes present in cellulolytic Clostridium and Ruminococcus species. In this study we created cellulolytic strains of Bacillus subtilis that display one or more cellulase enzymes. Proteins containing the appropriate cell wall sorting signal are covalently anchored to the peptidoglycan by coexpressing them with the Bacillus anthracis sortase A (SrtA) transpeptidase. This approach was used to covalently attach the Cel8A endoglucanase from Clostridium thermocellum to the cell wall. In addition, a Cel8A-dockerin fusion protein was anchored on the surface of B. subtilis via noncovalent interactions with a cell wall-attached cohesin module. We also demonstrate that it is possible to assemble multienzyme complexes on the cell surface. A three-enzyme-containing minicellulosome was displayed on the cell surface; it consisted of a cell wall-attached scaffoldin protein noncovalently bound to three cellulase-dockerin fusion proteins that were produced in Escherichia coli. B. subtilis has a robust genetic system and is currently used in a wide range of industrial processes. Thus, grafting larger, more elaborate minicellulosomes onto the surface of B. subtilis may yield cellulolytic bacteria with increased potency that can be used to degrade biomass.     

Developments in the use of Bacillus species for industrial production

Bacillus species continue to be dominant bacterial workhorses in microbial fermentations. Bacillus subtilis (natto) is the key microbial participant in the ongoing production of the soya-based traditional natto fermentation, and some Bacillus species are on the Food and Drug Administration's GRAS (generally regarded as safe) list. The capacity of selected Bacillus strains to produce and secrete large quantities (20-25 g/L) of extracellular enzymes has placed them among the most important industrial enzyme producers. The ability of different species to ferment in the acid, neutral, and alkaline pH ranges, combined with the presence of thermophiles in the genus, has lead to the development of a variety of new commercial enzyme products with the desired temperature, pH activity, and stability properties to address a variety of specific applications. Classical mutation and (or) selection techniques, together with advanced cloning and protein engineering strategies, have been exploited to develop these products. Efforts to produce and secrete high yields of foreign recombinant proteins in Bacillus hosts initially appeared to be hampered by the degradation of the products by the host proteases. Recent studies have revealed that the slow folding of heterologous proteins at the membrane-cell wall interface of Gram-positive bacteria renders them vulnerable to attack by wall-associated proteases. In addition, the presence of thiol-disulphide oxidoreductases in B. subtilis may be beneficial in the secretion of disulphide-bond-containing proteins. Such developments from our understanding of the complex protein translocation machinery of Gram-positive bacteria should allow the resolution of current secretion challenges and make Bacillus species preeminent hosts for heterologous protein production. Bacillus strains have also been developed and engineered as industrial producers of nucleotides, the vitamin riboflavin, the flavor agent ribose, and the supplement poly-gamma-glutamic acid. With the recent characterization of the genome of B. subtilis 168 and of some related strains, Bacillus species are poised to become the preferred hosts for the production of many new and improved products as we move through the genomic and proteomic era.     

<Emphasis Type="Italic">Lipomyces starkeyi</Emphasis>: an emerging cell factory for production of lipids,oleochemicals and biotechnology applications

Oils and oleochemicals produced by microbial cells offer an attractive alternative to petroleum and food-crop derived oils for the production of transport fuel and oleochemicals. An emerging candidate for industrial single cell oil production is the oleaginous yeast Lipomyces starkeyi. This yeast is capable of accumulating storage lipids to concentrations greater than 60% of the dry cell weight. From the perspective of industrial biotechnology L. starkeyi is an excellent chassis for single-cell oil and oleochemical production as it can use a wide variety of carbon and nitrogen sources as feedstock. The strain has been used to produce lipids from hexose and pentose sugars derived from cellulosic hydrolysates as well as crude glycerol and even sewage sludge. L. starkeyi also produces glucanhydrolases that have a variety of industrial applications and displays potential to be employed for bioremediation. Despite its excellent properties for biotechnology applications, adoption of L. starkeyi as an industrial chassis has been hindered by the difficulty of genetically manipulating the strain. This review will highlight the industrial potential of L. starkeyi as a chassis for the production of lipids, oleochemicals and other biochemicals. Additionally, we consider progress and challenges in engineering this organism for industrial applications.     

枯草芽孢杆菌微生态制剂发酵研究进展

微生态制剂是饲用抗生素的绿色有效替代品。枯草芽孢杆菌在逆境中可形成抗逆性强的芽孢,在生产和应用过程中保持高活性,是一种高效的微生态制剂菌种。提高枯草芽孢杆菌活菌数及芽孢率是保证微生态制剂产品质量的关键。本文综述了枯草芽孢杆菌芽孢形成的分子生物学机制及影响芽孢形成的重要因素,进一步比较枯草芽孢杆菌微生态制剂不同发酵方式的特点,重点阐述了提高枯草芽孢杆菌有效生物量的工艺优化,最后介绍了枯草芽孢杆菌微生态制剂的应用,并对将来研究思路进行了讨论。     

枯草芽孢杆菌生物茵剂对五味子白粉病防效及生长的影响

通过对不同年生五味子进行叶面喷施和根部灌施枯草芽孢杆菌生物菌剂进行田间试验,结果表明:(1)枯草芽孢杆菌生物菌剂对五味子白粉病有很好的抑制作用,喷施加灌施处理的发病率为13.0％,喷施的发病率为22.5％,清水对照的发病率为37.5％.对二年生、三年生、四年生五味子的防治效果分别为78.9％、77.8％、75.0％,这...